Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry E Gidal

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
Epilepsy Research|November 25, 2016
The application of half-life in clinical decision making: Comparison of the pharmacokinetics of extended-release topiramate (USL255) and immediate-release topiramateBarry E Gidal, Annie M Clark, Bob Anders, et al.
Epilepsy & Behavior : E&B|December 5, 2017
Optimizing clobazam treatment in patients with Lennox-Gastaut syndromeJouko Isojarvi, Barry E Gidal, Steve Chung, et al.
Epilepsy Research|August 31, 2010
The association between antiepileptic drug and HMG-CoA reductase inhibitor co-medication and cholesterol management in patients with epilepsySean D Candrilli, Ranjani Manjunath, Keith L Davis, et al.
Epilepsy Research|March 12, 2004
Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapyBarry E Gidal, Raj Sheth, Jennifer Parnell, et al.
Neurology|February 4, 2009
Assessment of potential drug interactions in patients with epilepsy: impact of age and sexBarry E Gidal, Jacqueline A French, Patricia Grossman, et al.
Epilepsy Research|December 4, 2003
Levetiracetam does not alter body weight: analysis of randomized, controlled clinical trialsBarry E Gidal, Raj D Sheth, Leslie Magnus, et al.
Neurology. Clinical Practice|January 3, 2024
Zonisamide: A Comprehensive, Updated Review for the ClinicianBarry E Gidal, Trevor Resnick, Michael C Smith, et al.
Epilepsy & Behavior : E&B|May 10, 2021
Use of extended-release and immediate-release anti-seizure medications with a long half-life to improve adherence in epilepsy: A guide for cliniciansBarry E Gidal, Jim Ferry, Larisa Reyderman, et al.
Epilepsy Research|June 22, 2002
Time course of lamotrigine de-induction: impact of step-wise withdrawal of carbamazepine or phenytoinGail D Anderson, Barry E Gidal, John A Messenheimer, et al.
Epilepsy & Behavior : E&B|January 8, 2022
Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitionersOwen S Miller, Edmund J Elder, Karen J Jones, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Epilepsy Research|November 25, 2016
The application of half-life in clinical decision making: Comparison of the pharmacokinetics of extended-release topiramate (USL255) and immediate-release topiramateBarry E Gidal, Annie M Clark, Bob Anders, et al.
Epilepsy & Behavior : E&B|December 5, 2017
Optimizing clobazam treatment in patients with Lennox-Gastaut syndromeJouko Isojarvi, Barry E Gidal, Steve Chung, et al.
Epilepsy Research|August 31, 2010
The association between antiepileptic drug and HMG-CoA reductase inhibitor co-medication and cholesterol management in patients with epilepsySean D Candrilli, Ranjani Manjunath, Keith L Davis, et al.
Epilepsy Research|March 12, 2004
Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapyBarry E Gidal, Raj Sheth, Jennifer Parnell, et al.
Neurology|February 4, 2009
Assessment of potential drug interactions in patients with epilepsy: impact of age and sexBarry E Gidal, Jacqueline A French, Patricia Grossman, et al.
Epilepsy Research|December 4, 2003
Levetiracetam does not alter body weight: analysis of randomized, controlled clinical trialsBarry E Gidal, Raj D Sheth, Leslie Magnus, et al.
Neurology. Clinical Practice|January 3, 2024
Zonisamide: A Comprehensive, Updated Review for the ClinicianBarry E Gidal, Trevor Resnick, Michael C Smith, et al.
Epilepsy & Behavior : E&B|May 10, 2021
Use of extended-release and immediate-release anti-seizure medications with a long half-life to improve adherence in epilepsy: A guide for cliniciansBarry E Gidal, Jim Ferry, Larisa Reyderman, et al.
Epilepsy Research|June 22, 2002
Time course of lamotrigine de-induction: impact of step-wise withdrawal of carbamazepine or phenytoinGail D Anderson, Barry E Gidal, John A Messenheimer, et al.
Epilepsy & Behavior : E&B|January 8, 2022
Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitionersOwen S Miller, Edmund J Elder, Karen J Jones, et al.
Pageof 9